ARKK Holdings of VCYT
Veracyte
Veracyte, Inc. operates in the field of genomic diagnostics, providing advanced diagnostic testing solutions to improve clinical outcomes for patients, primarily in the areas of oncology and pulmonology. The company generates revenue by offering its proprietary genomic tests to healthcare providers, which assist in more accurate diagnosis and treatment decisions, as well as by licensing its technology and intellectual property.
Trades of VCYT in ARKK
The ten most recent trades of Veracyte in the ARKK ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Sep 24, 2024 | Sell | $1,141,693 | 1.25% | 0.02% |
| Sep 11, 2024 | Sell | $3,762,040 | 4.49% | 0.07% |
| Sep 09, 2024 | Sell | $2,315,451 | 2.78% | 0.04% |
| Sep 04, 2024 | Sell | $2,136,616 | 2.44% | 0.04% |
| Sep 03, 2024 | Sell | $177,415 | 0.19% | 0.00% |
| Aug 30, 2024 | Sell | $248,187 | 0.27% | 0.00% |
| Aug 28, 2024 | Sell | $688,713 | 0.72% | 0.01% |
| Aug 12, 2024 | Sell | $2,126,143 | 2.38% | 0.04% |
| Aug 09, 2024 | Sell | $3,357,601 | 3.57% | 0.06% |
| Jul 10, 2024 | Buy | $784,361 | 1.17% | 0.01% |